Aurora Diagnostics LLC-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Aurora Diagnostics LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8011858
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月13日
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥27,250見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥54,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥81,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Aurora Diagnostics LLC (Aurora Diagnostics) is a healthcare service provider that offers pathology and hospital services. The center offers pathology services which include dermatology services, gastrointestinal pathology services, heamato-pathology services, pathology consultation, urologic pathology and women’s health services. Its hospital services comprise anatomic pathology consulting, professional component development, technical component development and management services. The center operates in Alabama, Arizona, Florida, Georgia, Massachusetts, Michigan, Minnesota, Nevada, New Hampshire, New Jersey, New York, North Carolina, South Carolina, Texas and Virginia. Aurora Diagnostics is headquartered in Palm Beach Gardens, Florida, the US.

Aurora Diagnostics LLC – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Aurora Diagnostics LLC, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Aurora Diagnostics LLC, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Aurora Diagnostics LLC, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Aurora Diagnostics LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Aurora Diagnostics LLC, Medical Devices Deals, 2011 to YTD 2017 9
Aurora Diagnostics LLC, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Aurora Diagnostics LLC, Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
Aurora Diagnostics Acquires Texas Hospital Pathology Practices from Brazos Valley 11
Acquisition 12
Aurora Diagnostics Acquires West Georgia Pathology 12
Aurora Diagnostics Completes Acquisition of Mid-Atlantic Pathology Services 13
Aurora Diagnostics LLC – Key Competitors 14
Aurora Diagnostics LLC – Key Employees 15
Aurora Diagnostics LLC – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Recent Developments 18
Corporate Communications 18
Sep 05, 2017: Christopher Rieder Joins Aurora Diagnostics as Chief Information Officer 18
Jul 11, 2016: Aurora Diagnostics Names Michael Grattendick Chief Financial Officer 19
May 31, 2016: Dr. F. Michael Walsh Is Named Chief Medical Officer of Aurora Diagnostics 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
Aurora Diagnostics LLC, Pharmaceuticals & Healthcare, Key Facts 2
Aurora Diagnostics LLC, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Aurora Diagnostics LLC, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Aurora Diagnostics LLC, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Aurora Diagnostics LLC, Deals By Therapy Area, 2011 to YTD 2017 8
Aurora Diagnostics LLC, Medical Devices Deals, 2011 to YTD 2017 9
Aurora Diagnostics LLC, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Aurora Diagnostics Acquires Texas Hospital Pathology Practices from Brazos Valley 11
Aurora Diagnostics Acquires West Georgia Pathology 12
Aurora Diagnostics Completes Acquisition of Mid-Atlantic Pathology Services 13
Aurora Diagnostics LLC, Key Competitors 14
Aurora Diagnostics LLC, Key Employees 15
Aurora Diagnostics LLC, Other Locations 16
Aurora Diagnostics LLC, Subsidiaries 17

★海外企業調査レポート[Aurora Diagnostics LLC-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Amines & Plasticizers Ltd (506248):企業財務及び戦略的SWOT分析
    Summary Amines & Plasticizers Ltd (APL) is a chemical manufacturing company that offers ethanolamines phthalate plasticizers. Its products include cemgrind, ethanolamines, alkyl alkanolamines, pharma intermediates, gas treating solvents, morpholine, pharma Intermediates and industrial gases. APL off …
  • BioView Ltd. (BIOV):企業財務及び戦略的SWOT分析
    Summary BioView Ltd. (BioView) is a medical device company that manufactures and markets innovative automated cell imaging and analysis solutions. The company offers products such as accord, accord plus, allegro plus, duet-3, encore, solo workstation, solo touch workstation and SoloWeb systems. Its …
  • Audi AG:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Audi AG Mergers and Acquisition …
  • Capella Photonics, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Capella Photonics, Inc. Mergers …
  • Newfield Exploration Company:企業のM&A・提携・投資分析
    Newfield Exploration Company - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Newfield Exploration Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and a …
  • MGC Diagnostics Corp (MGCD):企業財務及び戦略的SWOT分析
    Summary MGC Diagnostics Corp (MGC Diagnostics) is a medical device company that offers cardio- respiratory health solutions. The company offers PFT, metabolic (CPET/CPX), and indirect calorimetry products. Its PFT products include plethysmograph, pulmonary function systems, spirometry and forced osc …
  • Aviva plc:企業の戦略・SWOT・財務分析
    Aviva plc - Strategy, SWOT and Corporate Finance Report Summary Aviva plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Ube Industries, Ltd.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Ube Industries, Ltd. Mergers an …
  • Polysack Plastic Industries Ltd.の企業概要及び財務/SWOT分析
    Polysack Plastic Industries Ltd. Fundamental Company Report provides a complete overview of the company’s affairs. All available data is presented in a comprehensive and easily accessed format. The report includes financial and SWOT information, industry analysis, opinions, estimates, plus annual an …
  • Office National des Hydrocarbures et des Mines:企業のM&A・提携動向(石油・ガス分野)
    Summary Office National des Hydrocarbures et des Mines (ONHYM) is a laboratory services organization that provides research, exploration and exploitation of hydrocarbons and other non phosphate minerals. The organization offers services which include mineral laboratory, petroleum laboratory, oil and …
  • Skyworks Solutions, Inc. (SWKS):企業の財務及び戦略的SWOT分析
    Summary Skyworks Solutions, Inc. (Skyworks) is a semiconductor company that designs, produces, and sells analog and mixed signal semiconductors. The company offers products such as amplifiers, attenuators, circulators, demodulators, detectors, diodes, directional couplers, front-end modules, hybrids …
  • Narada Power Source Co., Ltd. (300068):企業財務及び戦略的SWOT分析
    Summary Narada Power Source Co., Ltd. (Narada Power) is a battery manufacturer that markets stored energy solutions. The company offers products, which include acme series, acmeG series, eos series, eosG series, TT series, TTG series, MP series, GP series, GPG series, HRL series, DC series, MPG seri …
  • CBIZ, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' CBIZ, Inc. Mergers and Acquisit …
  • Zhejiang Dian Diagnostics Co Ltd (300244):企業財務及び戦略的SWOT分析
    Summary Zhejiang DIAN Diagnostics Co Ltd (DIAN Diagnostics) is a medical device company that offers diagnostic products. The company outsources diagnostic services to its clients. It provides forensic authentication services, commercialization of diagnostic products, research and development in medi …
  • Egton Medical Information Systems Ltd (EMIS)-医療機器分野:企業M&A・提携分析
    Summary Egton Medical Information Systems Ltd (EMIS) is a medical technology company that develops and offers software solutions for the healthcare industry. The company offers software products such as EMIS web, which is used for clinical services; EMIS IQ for data extraction services; symphony tha …
  • Tarpon Towers, LLC:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Tarpon Towers, LLC Mergers and …
  • Kimura Unity Co., Ltd. (9368):企業概要、財務及び戦略的SWOT分析
    Summary KIMURA UNITY CO., LTD. (KIMURA) is a business and consumer service provider. The company offers logistics services, car services, information services, and staffing services. Its logistics services include outsourcing and contract work, logistics system development, and distribution equipmen …
  • Veolia Environnement SA (VIE):企業のM&A・提携動向(エネルギー分野)
    Summary Veolia Environnement SA (Veolia) is an optimized resource management company. It designs, develops and provides water, waste and energy management solution solutions. The company specializes in providing water and wastewater services, environmental services and energy services for the develo …
  • Bionure Farma SL-製薬・医療分野:企業M&A・提携分析
    Summary Bionure Farma SL (Bionure) is a healthcare service provider that provides treatment for ophthalmological diseases, with concentration on multiple sclerosis and glaucoma. The company concentrates on two conditions of vision impairment which include optic neuritis and neuromyelitis optica. Its …
  • Haci Omer Sabanci Holding A.S. (SAHOL):企業のM&A・提携動向(エネルギー分野)
    Summary Haci Omer Sabanci Holding A.S. (Sabanci Holding) is an industrial and financial conglomerate. The company carries out its operations under six business units, namely, banking, cement, energy, industrial, retail and insurance and others. The company offers consumer, commercial, SME, corporate …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆